• 제목/요약/키워드: Maternal plasma

검색결과 67건 처리시간 0.018초

임신부의 비타민 $B_{6}$ 섭취와 모체와 제대혈 및 태반 조직의 비타민 $B_{6}$농도 (Maternal Vitamin $B_{6}$ Intake and Vitamin $B_{6}$ Level in Maternal, Umbilical Cord Plasma and Placenta)

  • 안홍석;이금주;정환욱
    • Journal of Nutrition and Health
    • /
    • 제35권3호
    • /
    • pp.322-331
    • /
    • 2002
  • 본 연구는 정상만기분만 임신부 (30명)와 그들의 신생아를 대상으로 임신부와 비타민$B_{6}$ 섭취양상과 모체와 신생아 제대혈장 및 태반조직내의 비타민$B_{6}$ 농도를 측정하고 이들 농도와 임신결과와의 상관성을 조사하며, 모체에서 태아로 비타민$B_{6}$가 이동될 때, 태반의 역할을 규명하고자 하였다. 임신부의 평균 연령과 임신 전 체중 및 신장은 각각 25.9세, 53.8kg 및 161 cm 였으며, 임신 전 체중 및 신장은 각각 25.9세, 53.8 kg 및 161cm 였으며, 임신 전 BMI는 20.7kg/$m^2$로 정상 범위였다. 수축기와 이완기 평균 혈압은 122.5 mmHg 와 75.2mmHg의 결과로 안정적인 수준이었으며 헤모글로빈 농도와 헤마토크리트치는 12.1g/dl와 36.1%로 양호하였다. 연구대상자 중 93.3%에 해당하는 임신부가 영양보충제를 복용했으며 이 중 85.7%가 엽산과 철분이 포함된 빈혈 치료제를 이용한 것으로 조사되었다. 영양보충제의 평균 복용기간은 16.3주였다. 임신부가 1일 평균 열량 섭취량은 2189.5kcal로 권장량의 93.2%였으며, 단백질은 79.3g(113.3%)으로 권장량을 상회하였다. 비타민 B$_{6}$의 평균 섭취량은 권장량은 91.4%인 1.7mg이었고, 비타민 $B_{6}$의 평균 섭취량은 권장량은 91.4%인 1.7mg이었고, 비타민 $B_{6}$ 영양밀도와 단백질 g 당 섭취량은 각각 0.8와 0.02mg으로 양호한 결과였다. 그러나, 비타민$B_{6}$의 주된 공급식품이 곡류 및 전분류 (50%)와 야채 및 과일류 (33%)로 식물성 식품이 대부분이었다. 임신 말 모체 혈장과 신생아 제대혈장의 PLP 농도는 각각 16.7$\pm$4.1 nmol/l와 61.3$\pm$19.8 nmol/l로 제대혈장의 PLP 농도가 유의적으로 높았으며, 태반조직의 PLP 농도는 898.6$\pm$159.2ng/g으로 혈장의 PLP 농도에 비해 매우 높은 값을 보였다. 모체와 태반조직 및 신생아 제대혈장간 PLP 농도의 상관성을 조사한 결과, 모체 혈장과 태반 조직간 (p<0.0001), 태반 조직과 신생아 제대혈장간 (p<0.05), 모체 혈 장과 제대혈장간(p<0.05) 유의적인 양의 상관관계가 있었다.

Maternal Plasma Hepatocyte Growth Factor Concentrations in Women Who Subsequently Developed Preeclampsia

  • Kim, Shin Young;Park, So Yeon;Kim, Mi Jin;Kim, Moon Young;Choi, Kyu Hong;Kwak, Dong Wook;Han, Yoo Jung;Ryu, Hyun Mee
    • Journal of Genetic Medicine
    • /
    • 제9권2호
    • /
    • pp.78-83
    • /
    • 2012
  • Purpose: The aim of this nested case-control study was to investigate the association between hepatocyte growth factor (HGF) concentrations in maternal plasma and the risk of developing preeclampsia. Materials and Methods: Plasma HGF concentration were measured in 52 women who subsequently developed preeclampsia and 104 normal pregnant women at the time of genetic amniocentesis (15-20 weeks) by enzyme-linked immunosorbent assay. Results: Maternal plasma HGF concentrations were significantly higher in women with subsequent preeclampsia (median: 737.8 ng/mL vs. 670.4 ng/mL, P=0.003) than in normal controls. However, HGF concentrations were not significantly different between subgroups by preeclamptic complications. After adjusting for potential confounding factors, women with HGF concentrations ${\geq}702.5ng/mL$ had a 3.2-fold increased risk (95% CI 2.7-5.4, P<0.001) of subsequent development of preeclampsia compared with women with HGF concentrations <702.5 ng/mL. Conclusion: Elevated maternal plasma HGF concentrations in the early second-trimester are associated with an increased risk of developing preeclampsia.

Noninvasive fetal RHD genotyping using cell-free fetal DNA incorporating fetal RASSF1A marker in RhD-negative pregnant women in Korea

  • Han, Sung-Hee;Yang, Young-Ho;Ryu, Jae-Song;Kim, Young-Jin;Lee, Kyoung-Ryul
    • Journal of Genetic Medicine
    • /
    • 제12권2호
    • /
    • pp.100-108
    • /
    • 2015
  • Purpose: Conventional methods for the prenatal detection of fetal RhD status involve invasive procedures such as fetal blood sampling and amniocentesis. The identification of cell-free fetal DNA (cffDNA) in maternal plasma creates the possibility of determining fetal RhD status by analyzing maternal plasma DNA. However, some technical problems still exist, especially the lack of a positive control marker for the presence of fetal DNA. Therefore, we assessed the feasibility and accuracy of fetal RHD genotyping incorporating the RASSF1A epigenetic fetal DNA marker from cffDNA in the maternal plasma of RhD-negative pregnant women in Korea. Materials and Methods: We analyzed maternal plasma from 41 pregnant women identified as RhD-negative by serological testing. Multiplex real-time PCR was performed by amplifying RHD exons 5 and 7 and the SRY gene, with RASSF1A being used as a gender-independent fetal epigenetic marker. The results were compared with those obtained by postnatal serological analysis of cord blood and gender identification. Results: Among the 41 fetuses, 37 were RhD-positive and 4 were RhD-negative according to the serological analysis of cord blood. There was 100% concordance between fetal RHD genotyping and serological cord blood results. Detection of the RASSF1A gene verified the presence of cffDNA, and the fetal SRY status was correctly detected in all 41 cases. Conclusion: Noninvasive fetal RHD genotyping with cffDNA incorporating RASSF1A is a feasible, reliable, and accurate method of determining fetal RhD status. It is an alternative to amniocentesis for the management of RhD-negative women and reduces the need for unnecessary RhIG prophylaxis.

An overview of current knowledge about cell-free RNA in amniotic fluid

  • Jung, Yong Wook;Shin, Yun Jeong;Shim, Sung Han;Cha, Dong Hyun
    • Journal of Genetic Medicine
    • /
    • 제13권2호
    • /
    • pp.65-71
    • /
    • 2016
  • Cell-free nucleic acids (cf-NAs) originate in trophoblasts and are detected in the maternal plasma. Using innovative bioinformatic technologies such as next-generation sequencing, cf-NAs in the maternal plasma have been rapidly applied in prenatal genetic screening for fetal aneuploidy. Amniotic fluid is a complex and dynamic fluid that provides growth factors and protection to the fetus. In 2001, the presence of cf-NA in amniotic fluid was reported. Amniotic fluid is in direct contact with the fetus and is derived from fetal urine and maternal and fetal plasma. Therefore, these genetic materials have been suggested to reflect fetal health and provide real-time genetic information regarding fetal development. Recently, several studies evaluated the global gene expression changes of amniotic fluid cell-free RNA according to gestational age. In addition, by analyzing the transcriptome in the amniotic fluid of fetal aneuploidy, potential key pathways and novel biomarkers for fetal chromosomal aneuploidy were identified. Here, we review the current knowledge of cell-free RNA in amniotic fluid and suggest future research directions.

3,5,3'-triiodo-L-thyronine ($T_3$) 모체주사에 의한 조피볼락 (Sebastes schlegeli) 혈중, 알 및 난황낭 자어의 갑상선 호르몬 농도 변화 (Maternal Injection of 3,5,3'-triiodo-L-thyronine ($T_3$) Causes Changes of Thyroid Hormone Levels in Plasma, Eggs and Yolk-sac Larvae in Female Rockfish (Sebastes schlegeli))

  • 장영진;강덕영
    • 한국수산과학회지
    • /
    • 제31권5호
    • /
    • pp.721-726
    • /
    • 1998
  • 조피볼락 암컷의 난황형성기에 3,5,3'-triiodo-L-thyro-nine($T_3$)을 20mg/kg 체중으로 모체주사하여 어미의 혈중 THs 농도변화 및 알과 출산자어로의 THs 전이여부를 조사하였다. L-thyroxine($T_4$)의 경우. 어미의 혈중 및 출산직후 자어에서 $T_3$구와 대조구 사이에 농도 차이를 파악할 수 없었지만, 알에서는 $T_3$구가 대조구 보다 낮은 $T_4$함량을 나타냈다. 어미에게 $T_3$를 주사한 결과, 외인성 $T_3$가 24시간 이내에 어미의 혈중으로 빠르게 흡수되어 난소로 전이된 다음, 출산직후의 난황낭 자어에서도 지속적으로 체류하는 것으로 파악되었다. 일반적으로 난생경골어류에서 THs가 자어 발생 및 변태에 영향을 미치는 점을 고려해 볼 때, 외인성 $T_3$의 모체주사에 의해 조피볼락 자어의 생리활성을 증대시킬 수 있을 것이며, 종묘생산시 건강한 종묘의 생산 가능성이 높을 것으로 보인다.

  • PDF

Confirmation of Male Specific Fetal Free RNA in Maternal Plasma and Comparison of Accuracy on the Sex Determination using Real-time PCR Method in Korean Native Cattle

  • Lee, Sang-Ho;Park, Chul-Ho;Park, Jun-Tae;Park, Sang-Guk;Lee, Jin-A;Suh, Guk-Hyun;Oh, Ki-Seok;Son, Chang-Ho
    • 한국수정란이식학회지
    • /
    • 제28권4호
    • /
    • pp.343-348
    • /
    • 2013
  • Cell-free fetal RNA has been highlighted as useful tools for the fetal sex determination or other genetic inherent disorder. However, there is no knowledge about the sex determination using cell free fetal RNA in bovine field. Thus, the present study aimed to evaluate the presence of transcripts of DDX3Y, USP9Y and ZRSR2Y genes in maternal plasma of pregnant cows to determine the sex of the fetus using real-time quantitative polymerase chain reaction assay, and verify its accuracy, sensitivity and specificity compared with the molecular testing and the calf sex at birth. Transcripts of USP9Y and DDX3Y genes were expressed in the all plasma of males and females both the control group and the experimental group. However, ZRSR2Y gene was matched up with the molecular testing and the true sex in control group and has an overall accuracy of 82.6%, a sensitivity of 75%, and a specificity of 100% in experimental group. Therefore, these results indicated that real time PCR technique, as a noninvasive and cost-efficient method, is possible to determination fetal sex in the bovine species using circulating cell free RNA in maternal plasma and especially ZRSR2Y gene could be a good candidate for the RNA based sex determination work.

Noninvasive Prenatal Diagnosis using Cell-Free Fetal DNA in Maternal Plasma: Clinical Applications

  • Yang, Young-Ho;Han, Sung-Hee;Lee, Kyoung-Ryul
    • Journal of Genetic Medicine
    • /
    • 제8권1호
    • /
    • pp.1-16
    • /
    • 2011
  • 현재 사용되고 있는 침습적 산전진단법(양수천자, 융모막샘플링)은 1-2%의 태아 손실이 초래되어, 비침습적 산전진단법이 산전진단의 궁극적인 목표로 대두되어 왔다. 1997년 Dr. Lo에 의해서 임신부 혈장 내에 세포 유리 태아 DNA (cffDNA)의 존재가 발견된 후 비침습적 산전진단의 새로운 가능성이 열렸으며, 과거 10년간 이에 대한 연구의 많은 진전을 보여주고 있다. 최근에 cffDNA를 이용한 Hemophilia A와 듀센형 근이영양증 등 반성 유전병(X-linked disorders) 진단에 필수적인 산전태아의 성 판정과 RhD-음성 임신부에서 태아의 RhD유전자 핵형 분석 등이 이미 외국에서 임상적으로 적용되고 있으나, 한국에서는 아직 실용화되지 않고 있다. CffDNA의 임상 사용에는 여전히 많은 제약점이 있으며, 이는 임신부 혈장 내 cffDNA 양에 비해 많은 양의 모태 DNA가 존재하고, 종래에 사용되었던 특이적인 Y염색체 유전자(Y-specific gene)는 남아 태아 임신 시에만 적용된다는 것에 기인한 다. 따라서 모든 태아에 적용할 수 있는 태아 성과 무관한 마커(sex-independent universal fetal marker as internal positive controls)가 요구되며, 이를 이용하여 정확한 태아 DNA를 검출할 수 있다. 본 연구진은 국내 처음으로 임신부 혈장 내에 cffDNA를 이용하여 SRY 유전자, RhD-exon 7, 태아 성과 무관한 DNA마커(universal fetal DNA marker)로써 RASSF1A 유전자를 실시간 중합효소연쇄반응(RT- PCR)을 사용하여 뛰어난 결과를 얻었다. 이는 한국에서 처음으로 성공적으로 시도된 것이다. 연구결과에서 산전 태아 성 판별과 산후 태아의 성이 100% 일치하였으며, 임신 주기별 SRY 수치는 임신이 진행할수록 증가함을 확인할 수 있었다. 따라서 이러한 방법은 혈우병 A, 듀센형 근이영양증, 선천성 부신증식증과 연골 무형성증의 진단과 치료 상담에 이용할 수 있으며 50%에서 침습적인 방법을 줄일 수가 있다. 또한, RhD-음성 임신부 대상으로 태아의 성 판정과 RhD 태아 유전자형을 분석한 결과 RhD-음성 태아를 정확히 검출함으로써 앞으로 기존 양수천자 등 침습적 검사를 대체할 수 있을 것이다. 특히 이는 치료가 필요 없는 RhD-음성 태아에서 RhD-면역글로불린의 예방적 치료를 사전에 막을 수 있어, 임신부 건강을 보호하고 의료 비용을 줄일 수 있는 큰 장점을 가진다. 한국에서 최초로 시도된 임신부 혈장 내 cffDNA를 이용한 본 연구의 성공은 비침습적 산전진단 임상 적용의 새 길을 제시하였다. 따라서 이를 각 유전질환의 산전진단에 유용하게 활용하는 것은 태아와 임신부의 건강 증진과 의료비용 절약 등 개인과 국가에 많은 기여를 할 것으로 사료된다.

Plasma Concentrations of Fe, Cu, Mn, and Cr of Maternal and Umbilical Cord Blood during Pregnancy

  • Lee, Jong-Im;Lim, Hyeon-Sook;Cho, Young-Sook
    • Preventive Nutrition and Food Science
    • /
    • 제7권3호
    • /
    • pp.282-286
    • /
    • 2002
  • Anemia is prevalent among pregnant women in Korea, and Fe deficiency anemia is a major nutritional problem throughout the world. Because studies of Cu, Mn, and Cr levels excluding Fe are rare, we were interested in changes in the nutritional status of these trace minerals and their relationship to hematogenesis. Accordingly, we determined the changes in plasma Fe, Cu, Mn, and Cr concentrations of maternal and umbilical cord blood during pregnancy, and evaluated the relationships between them at different time points during pregnancy. A total of 81 women participated in the study: 26 subjects in the first trimester, 23 in the second, and 32 in the third trimester. Plasma Fe levels were lower significantly (p<0.05) in the third trimester. Plasma Cu level ($\mu\textrm{g}$/dL) in each trimester were 86.6$\pm$13.8, 111.6$\pm$27.9, and 114.0$\pm$29.7, respectively; with significant increases (p<0.()5) in the second and third trimester. Plasma Mn concentrations (pg/dL) in each trimester were 212.6$\pm$89.0, 234.0$\pm$140.0, and 240.3$\pm$166.0, respectively and tended to increase, though not significantly, as the pregnancies progressed. The plasma concentrations of Cr (pg/dL) in each trimester were 3.7$\pm$2.0, 3.1$\pm$1.0, and 2.4$\pm$1.2, respectively; and was significantly lower (p<0.05) in the third trimester. In umbilical cord blood, the plasma level of Fe was 194.8$\pm$74.6 $\mu\textrm{g}$/dL, Cu was 57.5$\pm$10.9 $\mu\textrm{g}$/dL, Mn was 482.4$\pm$111.1 pg/dL, and Cr was 9.3$\pm$2.8 pg/dL. Plasma concentrations of Fe, Cu, Mn, and Cr of cord blood were 300 %, 50 %, 200 %, and 370% as compared to those of maternal blood in the third trimester. These results suggest that an active transport mechanism for the transport of Fe, Mn, and Cr from mother to fetus may exist, whereas, for Cu, the placenta appears to have a blocking effect on the transport from mother to baby.

수유기에 식이와 함께 섭취한 DHA가 산모의 혈액과 모유의 지질조성에 미치는 영향 (The Influence of DHA Supplementation in Maternal Diets on Fatty Acid Compositions of Plasma Lipids and Human Milk)

  • 조여원
    • Journal of Nutrition and Health
    • /
    • 제29권2호
    • /
    • pp.213-222
    • /
    • 1996
  • The most abundant long-chain polyunsaturated fatty acid in brain lipids is docosahexaenoic acid(C22 : 6 N-3, DHA). It is incorporated into nerve tissues mostly in utero and during the first year of life. DHA in brain is derived from either pre-formed DHA in human milk or by infant hepatic synthesis from linolenic acid in milk. This study was designed to investigate the effects of DHA supplementation on fatty acid profiles in maternal plasma lipid and breast milk. Twenty lactating women participated in the study. Seven women took 3g of fish oil per day and vitamin E for 28 days starting from the day of giving birth. Five women consumed 1.5g of fish oil as well as tivamin E, and the rest took vitamin E supplements for the same period of time. Dietary questionnaires and 3 consecutive 24-h recalls were collected to evaluate theri nutritional status and food habits. Finding that DHA intake from fish was not significantly different among three experimental groups, the partcipants were instructed to continue eating their usual home diets. Milk samples were taken on the day of giving birth, as well as the 7th, 14th and 28th day being the supplement phase, and finally 2 weeks after the cessating of DHA supplements. The amounts of the fish oil supplements produced significant dose-dependent increased in the DHA content of milk and plasma, but to a lesser degree. Base-line for 28 days raised the level to 2.05$\pm$0.43% and 1.5g/day supplement produced DHA levels of 1.02$\pm$0.19%. The results of this study indicated that relatively small amount of dietary DHA supplementation significantly elevats DHA content in milk. This would clearly elevate the infant's DHA intake which in turn may have implications for the infant's brain development.

  • PDF

The Potential and Accuracy of RNA-based Fetal Sex Determination during Early Pregnancy Using Cell-Free Fetal RNA from Korean Native Cows (Bos taurus coreanae)

  • Lee, Sang-Ho;Oh, Ki-Seok;Park, Chul-Ho;Kim, Yong-Min;Lee, Jin-A;Sohn, Seong-Won;Son, Chang-Ho
    • 한국임상수의학회지
    • /
    • 제33권5호
    • /
    • pp.266-269
    • /
    • 2016
  • Cell-free fetal RNA is useful to determine fetal sex and detect other inherent genetic disorders. However, non-invasive fetal sex determination methods using fetal RNA from maternal plasma is not yet well established in studies pertaining to bovine animals. Thus, the aim of this study was to systematically evaluate the presence of the male-specific ZRSR2Y gene transcript in maternal plasma using Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) assays, and to verify its accuracy, sensitivity, and specificity in determining fetal sex between 30 and 100 days of gestation. Overall accuracy, sensitivity, and specificity of the ZRSR2Y gene transcripts in determining fetal sex were 89.1%, 86.3%, and 100%, respectively. The 30 to 100 days of gestation were further classified into five stages of gestation, and each stage had relatively high accurate, sensitive, and specific results. Overall, these results indicate that the expression of the ZRSR2Y gene can be used for fetal sex determination in bovine animals using circulating cell-free RNA in maternal plasma during early pregnancy.